Teva's Deal-Making Spurs Inflows To Israel ETFs
August 03, 2015 at 10:25 AM EDT
Israel-based Teva Pharmaceuticals (NASDAQ: TEVA) last week said it will pay $40.5 billion for Allergan(NYSE: AGN)'s generic ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|